Top Markets
Coin of the day
Enimmune corporation Enimmune corporation

Enimmune corporation

6564
Rankning i aktier #26781
Enimmune Corporation is a Taiwanese biopharmaceutical company primarily focused... Enimmune Corporation is a Taiwanese biopharmaceutical company primarily focused on the research, development, and commercialization of pharmaceutical products. Among its key offerings is Tuberculin PPD RT23 SSI, an approved diagnostic agent utilized in tuberculin tests to ascertain the presence of tuberculosis infection in patients. Beyond its existing products, Enimmune is heavily invested in developing vaccines aimed at combating a diverse array of infectious diseases. These include, but are not limited to, vaccines for enterovirus, pneumonia, norovirus, dengue fever, and Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Established in 2014, the company maintains its headquarters in Taichung City, Taiwan.
Aktiekurs
$0.52468396
Marknadsvärde
$37.85M
Förändring (1 dag)
1.23%
Förändring (1 år)
-4.53%
Land
TW
Handel Enimmune corporation (6564)

Kategori

Aktiekurshistorik för Enimmune corporation (6564)
Högsta slutkurs: $0.53 den 2026-08-01

Lägsta slutkurs: $0.89 den 2018-09-01
Aktiekurshistorik för Enimmune corporation från 2018 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) -7.73%
2025 -21.37%
2024 -30.67%
2023 -42.89%
2022 47.58%
2021 -3.50%
2020 86.97%
2019 -4.98%
2018 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$542.77 37.63%
US
$1.03K 55.84%
NL
$120.74 -14.98%
AU
$145.16 439.84%
US
$756.15 6.24%
CH